Beiersdorf (BEI) investor relations material

Opening remarks and agenda

• AGM held virtually with increased shareholder participation and full digital rights to speak, submit motions, and vote via the AGM system.

• Next in-person AGM planned for 2028, coinciding with Supervisory Board elections.

• Agenda, proposed resolutions, and supporting documents published in advance; all legal requirements for convening met.

Financial performance review

• 2025 turnover reached EUR 9.9 billion, with 2.4% organic growth; earnings and profitability improved year-on-year.

• Derma segment grew 11.7% organically, reaching EUR 1.5 billion; healthcare segment grew 9.3% to EUR 300 million.

• NIVEA turnover grew 0.9% to EUR 5.5 billion, below expectations; La Prairie turnover fell 4.5% to EUR 478 million.

• tesa segment grew 1.8% to EUR 1.7 billion, driven by industrial and e-commerce business.

• Dividend of EUR 1 per share proposed; share buyback program up to EUR 750 million planned over next two years.

• Forecast for 2026: flat to slightly positive organic sales growth, EBIT margin slightly below previous year.

Board and executive committee updates

• Supervisory Board fulfilled duties per law and governance code; meetings focused on financials, strategy, and sustainability.

• Executive Board remuneration system revised and approved, emphasizing long-term value creation and transparency.

• No major changes to Executive Board except Mr. Rasquinet's departure in July 2025.